Suppr超能文献

捷克高胆固醇血症患者低密度脂蛋白受体突变谱

Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients.

作者信息

Kuhrová V, Francová H, Zapletalová P, Freiberger T, Fajkusová L, Hrabincová E, Slováková R, Kozák L

机构信息

Research Institute of Child Health, Department of Biochemical and Molecular Genetics, Brno, Czech Republic.

出版信息

Hum Mutat. 2001 Sep;18(3):253. doi: 10.1002/humu.1185.

Abstract

The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter region and coding sequence of the low density lipoprotein receptor (LDLR) gene in 130 patients from 68 unrelated families resulted in the identification of 37 sequence variations. Thirty of them are most likely disease causing mutations. Nineteen mutations were novel (two nonsense, five missense, six nucleotide(s) insertions and six nucleotide(s) deletions). Their pathological effect can be predicted on the basis of their position with respect to previously reported mutations with an estimated reduction of the receptor activity and/or premature termination of translation. These results expand our knowledge of mutations responsible for FH. Seven nucleotide variations were characterized as silent polymorphisms. Hum Mutat 18:253, 2001.

摘要

我们研究的目的是确定导致捷克高胆固醇血症个体出现家族性高胆固醇血症(FH)表型的突变。为此,采用了异源双链分析、单链构象多态性分析(SSCP)、变性梯度凝胶电泳(DGGE)、DNA测序和PCR/限制性分析相结合的方法。对来自68个无亲缘关系家族的130名患者的低密度脂蛋白受体(LDLR)基因启动子区域和编码序列进行分子筛查,共鉴定出37个序列变异。其中30个很可能是致病突变。19个突变是新发现的(2个无义突变、5个错义突变、6个核苷酸插入和6个核苷酸缺失)。根据它们相对于先前报道突变的位置,可以预测其病理效应,估计会降低受体活性和/或导致翻译提前终止。这些结果扩展了我们对导致FH的突变的认识。7个核苷酸变异被鉴定为沉默多态性。《人类突变》18:253,2001年。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验